related documents
- 12-MONTH PERSISTENCE WITH DENOSUMAB THERAPY AMONG OSTEOPOROTIC WOMEN IN THE CANADIAN PATIENT-SUPPORT PROGRAM Conferences
- ANTIOSTEOPOROSIS MEDICATION USE REMAINS LOW AFTER FRACTURE BUT IS RELATED TO SELF PERCEIVED FRACTURE RISK: FINDINGS FROM THE GLOW STUDY Conferences
- EFFECT OF TERIPARATIDE ON HEALING OF INCOMPLETE ATYPICAL FEMUR FRACTURES Conferences
- FRACTURE PATTERNS WITH SELECTIVE SEROTONIN RECEPTOR INHIBITOR, PROTON PUMP INHIBITOR AND GLUCOCORTICOIDS USE IN GLOW Conferences
- FURTHER REDUCTION IN NONVERTEBRAL FRACTURE RATE IS OBSERVED FOLLOWING 3 YEARS OF DENOSUMAB TREATMENT: RESULTS WITH UP TO 7 YEARS IN THE FREEDOM EXTENSION Conferences
- HOW WELL DOES SELF-PERCEPTION OF FRACTURE RISK RELATE TO FRACTURE PROBABILITY USING FRAX? FINDINGS FROM THE GLOW STUDY Conferences
- NOVEL DIAGNOSTIC TOOL: IN VIVO BONE STRONTIUM QUANTIFICATION, RECENT DEVELOPMENTS Conferences
- OSTEONECROSIS OF THE JAW: REPORT FROM THE INTERNATIONAL ONJ TASK FORCE Conferences
- OSTEOPOROSIS THERAPY, BEYOND FRACTURE PREVENTION Conferences
- PREVENTION OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS Conferences
- RECOMMENDATIONS FOR OSTEOPOROSIS MANAGEMENT AND FRACTURE PREVENTION FOR THE FRAIL ELDERLY IN LONG-TERM CARE (LTC) Conferences
- RELATIONSHIP OF WEIGHT, HEIGHT, AND BODY MASS INDEX WITH FRACTURE RISK AT DIFFERENT SITES IN POSTMENOPAUSAL WOMEN: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN (GLOW) Conferences
- TOO FIT TO FRACTURE: INTERNATIONAL CONSENSUS TO ESTABLISH RECOMMENDATIONS ON EXERCISE AND SAFE MOVEMENT FOR INDIVIDUALS WITH OSTEOPOROSIS AND SPINE FRACTURES Conferences